The president of the Federal Supreme Court, Luiz Fux, overturned the decision of the Federal Court of Accounts (TCU) and authorized the federal government to proceed with the purchase of R$ 310 million of human immunoglobulin 5g, a drug used to treat various diseases, among they HIV.
read more:
The judge cited the risk of shortages in the Unified Health System and released the signing of a contract between the Ministry of Health and Nanjing Pharmacare, from China.
The full court of accounts had decided to suspend the acquisition on the grounds that the company that won the electronic auction held by the Executive had prices 36% higher than its competitors.
TCU hosted a representation from Virchow Biotech, which was placed first in the event, but ended up disqualified because the Ministry of Health understood that the medicine sold by the company does not meet the technical qualification requirements.
Fux reversed TCU’s decision and authorized the purchase of medicines for a period of 60 days to avoid shortages in the SUS.
“In fact, it is a judicial solution that allows time for the Public Administration to proceed with the emergency contracts in force or acquire the strictly necessary medications”, he wrote in the decision signed on December 29th.
Credits: Folha de São Paulo.
The president of the Federal Supreme Court, Luiz Fux, overturned the decision of the Federal Court of Accounts (TCU) and authorized the federal government to proceed with the purchase of R$ 310 million of human immunoglobulin 5g, a drug used to treat various diseases, among they HIV.
read more:
The judge cited the risk of shortages in the Unified Health System and released the signing of a contract between the Ministry of Health and Nanjing Pharmacare, from China.
The full court of accounts had decided to suspend the acquisition on the grounds that the company that won the electronic auction held by the Executive had prices 36% higher than its competitors.
TCU hosted a representation from Virchow Biotech, which was placed first in the event, but ended up disqualified because the Ministry of Health understood that the medicine sold by the company does not meet the technical qualification requirements.
Fux reversed TCU’s decision and authorized the purchase of medicines for a period of 60 days to avoid shortages in the SUS.
“In fact, it is a judicial solution that allows time for the Public Administration to proceed with the emergency contracts in force or acquire the strictly necessary medications”, he wrote in the decision signed on December 29th.
Credits: Folha de São Paulo.